Recent Comments

Comment RSS

Coronary Artery Disease News and Research RSS Feed - Coronary Artery Disease News and Research

Coronary artery disease is the most common type of heart disease and the leading cause of death worldwide. It occurs when the arteries that supply blood to the heart become narrowed or blocked by a buildup of "plaque" - cholesterol or other fatty deposits that build on the inner wall of the artery. Over time, this plaque build up results in a reduction of blood flow to the heart, which can cause chest pain. If the artery becomes completely blocked, usually by a blood clot, oxygen is prevented from reaching the heart which can result in a heart attack and/or damage to the heart tissue.

Review of study presented at American Heart Association Scientific Sessions

21. November 2009 03:29
Adding the cholesterol drug niacin to a statin improved HDL ("good") cholesterol levels and significantly reduced carotid arterial plaque buildup measured with ultrasound within 8 months, with further improvement seen at the end of the study (14 months). [More]

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

19. November 2009 00:47
The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. [More]

Key findings from AstraZeneca's phase II studies of ticagrelor

18. November 2009 10:42
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation. [More]

Clinical Data commences patient enrollment in Stedivaze Phase III trial

18. November 2009 08:13
Clinical Data, Inc. today announced that it has enrolled the first patient in its initial Phase III trial of Stedivaze™, a potential best-in-class vasodilator for use in cardiac stress testing. The study will evaluate the safety and efficacy of Stedivaze (apadenoson) for use as a pharmacologic stress agent in myocardial perfusion imaging (MPI), a method for detecting defects in the blood supply to the heart. [More]

First gene expression test for coronary artery disease

18. November 2009 02:03
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain. [More]

Report on the U.S. cardiac surgery devices market

18. November 2009 01:46
In 2008, the U.S. market for cardiac surgery devices was valued at over $1.6 billion, representing growth of nearly 7% over 2007. [More]

Aterovax presents results of its sPLA2 activity test in the PEACE trial

17. November 2009 04:29
Aterovax SA, a company developing innovative products for atherosclerosis, today announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease (CAD) over a 5 year period, independent of established risk markers, including C-reactive protein. [More]

Statin therapy should still be used first to reach blood cholesterol levels before considering niacin

17. November 2009 01:03
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Cardiovascular atherosclerosis, as it is also known, is believed responsible for one in three deaths in the United States each year. [More]

Sudden cardiac death more predictable in men than women

17. November 2009 00:29
A woman who suffers sudden cardiac arrest is significantly less likely than a man to exhibit the decrease in the heart's pumping ability that is widely recognized as a precursor, says a new study in the Nov. 24 Journal of the American College of Cardiology. [More]

Posted in: Medical Condition News

Tags: , , , , , ,

Stem cell therapy to treat heart, lung and vascular diseases show positive results

16. November 2009 23:32
A Florida cardiologist is using stem cell therapy to treat patients who suffer from a range of heart, lung and vascular illnesses. The results have been extraordinary. [More]

Effect of niacin or ezetimibe added to chronic statin therapy on carotid intima media thickness: Study

16. November 2009 05:56
In combination with statins, adding a medication that raises high-density lipoprotein (HDL) cholesterol was more effective in reversing artery wall plaque buildup and in reducing heart disease risk than adding a drug that lowers low-density lipoprotein (LDL) cholesterol, researchers reported today at the American Heart Association Scientific Sessions 2009. [More]

Cappella commences evaluation of the Sideguard Coronary Sidebranch Stent & Delivery System

16. November 2009 03:47
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries. [More]

Posted in: Device / Technology News

Tags: ,

Vitamin D deficiency may increase risk of stroke, heart disease and death, finds study

16. November 2009 03:22
While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong and healthy heart as well - and that inadequate levels of the vitamin may significantly increase a person's risk of stroke, heart disease, and death, even among people who've never had heart disease. [More]

Phase I clinical study for ETC-1002 commenced

16. November 2009 00:14
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins. [More]

Posted in: Drug Trial News | Pharmaceutical News

Tags: , , , , ,

Insight into the pipeline status of atherosclerosis or coronary artery disease drugs

13. November 2009 04:48
Life Science Analytics', Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of atherosclerosis or coronary artery disease drugs by company and by stage as well as a summary of the latest news and developments in this area. [More]

Posted in: Pharmaceutical News

Tags: ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.